Goodwin
Kuwabo Mubyana
- Deals
- 2
- Latest
- Apr 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 2 deals
Often works with
- Michael Shuster 1 deal together
- Maria C. Smith 1 deal together
- Christopher Bodle 1 deal together
- Catherine Amaya 1 deal together
- Chris McKenna 1 deal together
- Vicki Vann 1 deal together
- Danielle Moten 1 deal together
- Tavid Bingham 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Apr 2026 | Tubulis | EQT Life Sciences (LSP 7 fund) | Gilead Sciences | Acquisition | Legal adviser to Tubulis (target) | Announced | 3,150.0 | Biotech+2 | Gilead Sciences acquisition of Tubulis |
| Jan 2026 | Aktis Oncology | – | – | IPO | Legal adviser to the issuer | Listed | 317.7 | Biotech+2 | Aktis Oncology IPO |
Deals where Kuwabo Mubyana is named on the firm's deal team, by the firm or the press.